Pharmacokinetic Study of JNJ-42756493 in Healthy Participants

NCT02218073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-42756493 10 mg tablet
DRUG: JNJ-42756493 10 mg Oral Solution
DRUG: JNJ-61818549

Sponsor

Janssen Research & Development, LLC